Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call shows mixed results: strong commercial and health division growth, positive operating profit, and increased gross margins are countered by declines in U.S. consumer business and full-year revenue. The Q&A highlights uncertainty in tariff impacts and lack of clarity on sales resumption details. While new partnerships and product pipelines offer future growth potential, increased costs and economic uncertainties pose risks. The combination of these factors suggests a neutral stock price movement over the next two weeks.
Fourth Quarter Revenue $212.9 million, a decline of just 30 basis points year-over-year. The decline was due to lower sales volumes in the U.S. consumer business, although there was growth in commercial and health businesses.
Fourth Quarter Operating Profit $25.4 million, an 8% increase year-over-year. This was driven by a 220 basis point increase in gross margins to 28.3%, reflecting improved pricing strategies, customer and product mix, and growth in commercial and health divisions.
Full Year Revenue $606.9 million, down 7.3% year-over-year. The decline was attributed to lower volumes in the U.S. consumer business due to tariff-related disruptions and changes in retailer buying patterns.
Full Year Operating Profit (Adjusted) $43.5 million, an increase from $43.2 million in 2024. This excludes $5.3 million in one-time incremental tariffs and $1.6 million from accelerated depreciation and write-off of the legacy ERP system.
Full Year Net Income $26.5 million, down from $30.8 million in 2024. The decline was due to higher tax rates and the impact of one-time expenses.
Commercial Business Growth Grew over 15% for the year, driven by the success of the Summit Edge blender and new agreements like the Sunkist branded commercial juicers.
Hamilton Beach Health Operating Profit Achieved positive operating profit in Q3 and Q4 of 2025, driven by expanded specialty pharmacy partnerships and the launch of HealthBeacon Harmony software products.
Gross Profit Margin (Fourth Quarter) 28.3%, a 220 basis point improvement year-over-year, due to favorable product and customer mix, labor and logistics efficiencies, and pricing strategies.
Net Cash Provided by Operating Activities (Full Year) $13.8 million, down from $65.4 million in 2024. The decrease was due to increased net working capital and lower accounts payable.
Launch of Lotus brand: The premium Lotus brand was successfully launched, exceeding expectations with strong double-digit sell-through results. Retailers have committed to increased shelf space for broader market reach.
Summit Edge blender: The commercial Summit Edge blender, featuring advanced blending and mixing technologies, contributed to over 15% growth in the commercial business.
Sunkist branded products: Launched Sunkist branded commercial juicers and sectionizers in Q2, with demand exceeding expectations from restaurants, hospitality chains, and schools.
HealthBeacon Harmony software: Successfully launched HealthBeacon Harmony software products with Novartis, expanding the patient subscription base by 50%.
Premium market expansion: Lotus brand expansion targets the premium market, which represents half of the U.S. appliance market ($4 billion). The company currently holds only 1% market share, indicating significant growth potential.
Global commercial market: Focus on expanding relationships with large food service and hospitality chains, with emphasis on regional and global chain penetration.
Manufacturing diversification: Diversified manufacturing away from China to other APAC countries like Vietnam, Thailand, and Indonesia, enhancing supply chain resilience and flexibility.
Digital transformation: Increased investment in digital, social media, and influencer marketing, along with AI shopping tactics to improve consumer discoverability.
Strategic cost management: Implemented pricing optimization, comprehensive cost management, and proactive inventory management to navigate tariff-related disruptions.
ERP system transition: Accelerated depreciation and write-off of the legacy ERP system, with plans for a new system to enhance operational efficiency.
Tariff-related disruptions: The company faced significant industry-wide disruptions due to unprecedented tariff increases in 2025, leading to a 7% decline in full-year revenue and a 6-week suspension of purchasing by retailers during the height of tariff uncertainty.
Decline in U.S. consumer business: Lower sales volumes in the U.S. consumer business were attributed to retailers adjusting their buying patterns in response to higher tariffs.
Expiration of licensing agreement: The expiration of the Bartesian licensing agreement at the end of 2025 is expected to create a $22 million sales headwind in 2026.
Increased advertising and ERP costs: The company plans to increase advertising investment significantly in 2026 and will incur $6 million in accelerated depreciation costs associated with replacing its legacy ERP system, which will impact operating profit.
Economic uncertainties and supply chain challenges: The company highlighted the need for manufacturing diversification to mitigate risks from changing tariff policies and economic conditions, which could impact supply chain resilience and costs.
Revenue Growth: The company expects revenue growth to approach the mid-single-digit range in 2026, weighted towards the second and third quarters.
Gross Margins: Gross margins for 2026 are expected to be similar to or slightly better than 2025.
Operating Profit: Operating profit is expected to decline in the low teens percentage-wise, inclusive of $6 million in accelerated depreciation for the legacy ERP system and an additional $6 million in planned advertising spend.
Cash Flow: Cash flow from operating activities less cash used for investing activities is expected to range between $35 million and $45 million in 2026.
Product Launches: The company plans to launch three new blender systems, a redesigned Durathon Iron platform, new garment steamers, and two new single-serve coffee platforms in 2026.
Marketing Investments: Advertising investment in 2026 will exceed the combined total of the past four years, with a focus on digital, social media, and influencer marketing.
Premium Market Expansion: The Lotus Signature line is scheduled to launch in fall 2026, supported by a $6 million marketing investment over 15 months.
Commercial Market Growth: The company plans to expand relationships with large food service and hospitality chains and launch multiple automated beverage products.
Health Division Growth: The company will trial a pill management platform in Q2 2026, targeting oncologic and mental health areas, and plans to expand its distribution network with specialty pharmacies.
Dividends Paid: $6.4 million in dividends were paid in 2025.
Share Repurchase: Approximately 507,000 shares were repurchased totaling $9 million in 2025.
The earnings call shows mixed results: strong commercial and health division growth, positive operating profit, and increased gross margins are countered by declines in U.S. consumer business and full-year revenue. The Q&A highlights uncertainty in tariff impacts and lack of clarity on sales resumption details. While new partnerships and product pipelines offer future growth potential, increased costs and economic uncertainties pose risks. The combination of these factors suggests a neutral stock price movement over the next two weeks.
The earnings call highlights several concerns: a significant revenue decline, increased net debt, and cash flow issues due to shorter payment terms. Although there are positive developments like resumed orders from a large retailer and cost management measures, the lack of guidance and ongoing economic uncertainty overshadow these positives. The Q&A session did not alleviate concerns, especially regarding tariffs and financial pressures. These factors suggest a negative market reaction, likely leading to a stock price decline between -2% and -8% over the next two weeks.
The earnings call reveals several concerns: a significant revenue decline, increased net debt, and cash flow issues. Although there are positive aspects like improved gross margins and strategic initiatives, the suspension of guidance due to tariff unpredictability and the lack of clear growth projections weigh heavily. Share repurchases and cost-saving measures are positive, but the overall financial performance and uncertainties suggest a negative sentiment. The Q&A section confirms these concerns, with management avoiding direct answers on growth alignment with GDP, further justifying a negative outlook.
The earnings call presents a mixed outlook. Financial performance shows improvement with revenue and profit growth, but the suspension of guidance due to tariff and economic uncertainties raises concerns. The Q&A reveals management's cautious stance on margins and retailer relations. Positive factors include debt reduction and shareholder returns through dividends and buybacks. However, the lack of guidance and market competition pressures balance these positives, suggesting a neutral stock price reaction in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.